Key Takeaways
- Johnson Controls International (JCI) raised its full-year adjusted EPS guidance to approximately $4.70 from $4.55, following a strong Q1 adjusted EPS of $0.89 which surpassed estimates. The company also recognized a $70 million pre-tax gain from the sale of its ADT Mexico security business.
- AbbVie (ABBV) reported Q4 global RINVOQ net revenue of $2.37 billion, falling short of the $2.41 billion estimate, but provided an optimistic 2026 adjusted EPS outlook of $14.37 – $14.57, exceeding the $14.24 estimate. The company's Q4 results were impacted by a $0.71 per share expense related to acquired IPR&D and milestones.
- Eighty Democratic lawmakers have urged the Trump administration to withdraw a proposal that would weaken vehicle fuel economy standards.
- Senator Tillis indicated he would support Kevin Warsh's nomination for the Federal Reserve once a probe into Jerome Powell is settled, calling Warsh a "great pick."
Companies are navigating a dynamic financial landscape, with Johnson Controls International (JCI) and AbbVie (ABBV) releasing significant updates on their financial performance and outlook. Meanwhile, political developments are unfolding on multiple fronts, from environmental regulations to Federal Reserve appointments and international arms treaties.
Johnson Controls Elevates Full-Year Guidance Amid Strategic Divestment
Johnson Controls International (JCI) reported a mixed first quarter, with sales of $3,843 million missing the $5,639 million estimate. However, the company's adjusted earnings per share (EPS) for Q1 stood at $0.89, comfortably beating the analyst estimate of $0.84. Net income for the quarter was $555 million.
Looking ahead, Johnson Controls has raised its full-year continuing operations adjusted EPS guidance to approximately $4.70 from $4.55, indicating confidence in future performance. The company also anticipates Q2 organic sales growth of 5% and projected Q2 adjusted EPS of $1.11. This positive outlook comes as the company recognized a pre-tax gain of $70 million from the sale of its ADT Mexico security business, a move that aligns with its strategic focus. The divestiture allows Johnson Controls to concentrate on core areas with higher growth potential, streamlining operations and enhancing shareholder value.
AbbVie's RINVOQ Revenue Misses, but 2026 EPS Outlook Impresses
Pharmaceutical giant AbbVie (ABBV) announced its Q4 global RINVOQ net revenue reached $2.37 billion, slightly below the estimated $2.41 billion. Despite this, the company's 2026 adjusted EPS outlook is projected to be between $14.37 and $14.57, surpassing the analyst estimate of $14.24.
The Q4 results included an unfavorable impact of $0.71 per share related to acquired in-process research and development (IPR&D) and milestones expense. This charge of $1.3 billion impacts both GAAP and non-GAAP diluted EPS. Despite the revenue miss for RINVOQ, AbbVie anticipates another year of robust growth, with its strategic acquisitions in neuroscience and oncology bolstering its portfolio.
Political Landscape: Fuel Economy, Fed Appointments, and Arms Treaties
In the political arena, 80 Democratic lawmakers have sent a letter to the Trump administration, urging it to withdraw a proposal aimed at weakening vehicle fuel economy standards. Critics argue that loosening these regulations could lead to increased carbon dioxide emissions and harm domestic manufacturers investing in electric vehicle technologies.
Regarding Federal Reserve appointments, Senator Tillis stated he would support Kevin Warsh as a nominee for the Fed, calling him a "great pick." However, Tillis's support is contingent on the resolution of a probe into Jerome Powell. This stance creates uncertainty for the confirmation process, as Tillis's opposition alone could block Warsh's nomination in the Senate Banking Committee.
Internationally, the Russian Foreign Ministry is set to publish a document concerning the New START arms treaty on Wednesday. The New START treaty, which limits the deployed strategic nuclear arsenals of the United States and Russia, is set to expire, raising concerns about a potential new arms race.
The Russian Foreign Ministry stated there is no reason to believe India has reconsidered its energy cooperation with Russia. This comes amidst ongoing geopolitical tensions and scrutiny over international energy alliances.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.